We must embrace change and lead new models of care

0
Since becoming National President, I have received significant levels of feedback in support of PSA’s development of pharmacists working in general practice. I have also...

PSA18 maps out the future of pharmacy

0
PSA18 has wrapped up in Sydney, with the future of pharmacy firmly in sight as PSA presented the Pharmacists in 2023 Discussion Paper, a...

Call to enlist pharmacists for opioid fight as deaths rise

0
New Australian Institute of Health and Welfare (AIHW) research has revealed the number of Australian deaths involving opioids has more than doubled in the...

PBS listings for cancer, Parkinson’s and motor neurone disease

0
Since 1 April, medicines crucial to those suffering from cancer, Parkinson’s and motor neurone disease have become available on the Pharmaceutical Benefits Scheme (PBS). The...

Pharmacists welcome new SA Health Minister

0
The appointment of new South Australian Health Minister Peter Malinauskas MLC was welcomed by the PSA SA/NT Branch last month. Mr Malinauskas has replaced former...

Pregabalin add-on for drug-resistant focal epilepsy

0
This evidence summary presents the best available evidence regarding pregabalin add-on for drug-resistant focal epilepsy.1 Introduction Approximately 3–3.5% of Australians will experience epilepsy at some point...